SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-031026
Filing Date
2019-02-07
Accepted
2019-02-07 17:27:02
Documents
13
Period of Report
2019-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d684748d8k.htm 8-K 34232
2 EX-1.1 d684748dex11.htm EX-1.1 185200
3 EX-4.2 d684748dex42.htm EX-4.2 283079
4 EX-4.3 d684748dex43.htm EX-4.3 464156
5 EX-5.1 d684748dex51.htm EX-5.1 16290
6 EX-5.2 d684748dex52.htm EX-5.2 11630
7 EX-10.1 d684748dex101.htm EX-10.1 94539
8 GRAPHIC g684748dsp51.jpg GRAPHIC 2528
9 GRAPHIC g684748dsp52.jpg GRAPHIC 19363
10 GRAPHIC g684748dsp54.jpg GRAPHIC 3265
11 GRAPHIC g684748dsp55.jpg GRAPHIC 3537
12 GRAPHIC g684748dsp56.jpg GRAPHIC 3006
13 GRAPHIC g684748dsp57.jpg GRAPHIC 4362
  Complete submission text file 0001193125-19-031026.txt   1141178
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 19576162
SIC: 2834 Pharmaceutical Preparations